FDA Planning to Survey Drug Firms as Part of Pharmaceutical Development Study

Drug Industry Daily
KEYWORDS FDA
A A

The FDA’s Office of Pharmaceutical Science (OPS) is planning to partner with a California-based software company to collect a wide variety of information from drug manufacturers that the agency hopes will further its efforts to improve the drug-development process.

To View This Article:

Login

Subscribe To Drug Industry Daily